Mayo Clinic
R. Houston Thompson, MD, completed his Urology Residency at Mayo Clinic Rochester in 2007 followed by a Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center. He is currently Professor of Urology at Mayo Clinic Rochester. Dr. Thompson is involved in clinical and translational research in urologic oncology and has >200 peer-reviewed original articles. Notable contributions to the literature include discovery that PD-1 and PD-L1 are aberrantly expressed in the microenvironment of renal cell carcinoma tumors, and thus represent attractive therapeutic targets.
Disclosure information not submitted.
Sunday, May 15, 2022
4:30 PM – 5:45 PM